Casdin Capital, LLC
SEC CIK 1534261 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | Dir, 10% | 3.71M | $36.49M | — | 4 | 2024-05-13 | 2026-06-04 |
| BLFS | BIOLIFE SOLUTIONS INC | 10% | 6.71M | — | $12.20M | 1 | 2025-08-15 | 2025-08-15 |
| LAB | STANDARD BIOTOOLS INC. | Dir, 10% | 59.39M | $5.16M | — | 4 | 2024-06-18 | 2025-02-28 |
| TNYA | Tenaya Therapeutics, Inc. | Dir | 6.08M | $6.48M | — | 1 | 2022-11-17 | 2022-11-17 |
| MXCT | MAXCYTE, INC. | 10% | 10.00M | — | $18.44M | 2 | 2022-07-01 | 2022-10-03 |
| ABSI | Absci Corp | Dir | 4.21M | $25.00M | — | 3 | 2021-07-26 | 2021-07-26 |
Most active insiders at WGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir, 10% | $74.03M | — |
| 2 | Casdin Capital, LLC | Dir, 10% | $32.57M | — |
| 3 | Stueland Katherine | CEO, Dir | — | $12.90M |
| 4 | RUCH JOSHUA | Dir | — | $6.09M |
| 5 | Feeley Kevin | CFO | — | $4.07M |
| 6 | Dechairo Bryan | COO | — | $850.6K |
| 7 | Fuchs Thomas | Dir | — | — |
| 8 | Leproust Emily M. | Dir | — | — |
| 9 | Ryan Jason | Dir | — | — |
| 10 | Casdin Eli | Dir, 10% | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-06-08 17:25 | 2026-06-04+ | WGS | GeneDx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $55.55 | +200.0K | 3.71M | +6% | +$11.11M |
| MI | 2026-05-20 19:45 | 2026-05-18+ | WGS | GeneDx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $42.92 | +500.0K | 3.51M | +17% | +$21.46M |
| I | 2025-08-21 | 2025-08-15 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Capital, LLC | 10% | S - Sale | $24.40 | -500.0K | 6.71M | -7% | -$12.20M |
| MI | 2025-03-04 | 2025-02-28 | LAB | STANDARD BIOTOOLS INC. | Casdin Capital, LLC | Dir, 10% | J - Other | $1.07 | 0 | 59.39M | New | $0 |
| I | 2025-03-04 | 2025-02-28 | LAB | STANDARD BIOTOOLS INC. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $1.07 | +4.82M | 58.85M | +9% | +$5.16M |
| 2025-03-04 | 2025-02-28 | LAB | STANDARD BIOTOOLS INC. | Casdin Capital, LLC | Dir, 10% | A - Grant | $1.07 | +58.2K | 2.81M | +2% | +$62.3K | |
| MI | 2024-06-21 | 2024-06-18 | LAB | STANDARD BIOTOOLS INC. | Casdin Capital, LLC | Dir, 10% | J - Other | $2.05 | 0 | 545.0K | New | $0 |
| M | 2024-06-05 | 2024-06-03+ | WGS | GeneDx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $21.21 | +130.0K | 3.06M | +4% | +$2.76M |
| 2024-05-15 | 2024-05-13 | WGS | GeneDx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $23.31 | +50.0K | 2.75M | +2% | +$1.17M | |
| DI | 2022-11-25 | 2022-11-17 | TNYA | Tenaya Therapeutics, Inc. | Casdin Capital, LLC | Dir | P - Purchase | $2.60 | +2.49M | 6.08M | +69% | +$6.48M |
| 2022-10-05 | 2022-10-03 | MXCT | MAXCYTE, INC. | Casdin Capital, LLC | 10% | S - Sale | $6.15 | -735.8K | 10.00M | -7% | -$4.53M | |
| 2022-07-06 | 2022-07-01 | MXCT | MAXCYTE, INC. | Casdin Capital, LLC | 10% | S - Sale | $4.30 | -3.24M | 10.74M | -23% | -$13.91M | |
| DM | 2021-07-28 | 2021-07-26 | ABSI | Absci Corp | Casdin Capital, LLC | Dir | C - Cnv Deriv | $0.00 | +5.18M | 4.21M | New | $0 |
| D | 2021-07-28 | 2021-07-26 | ABSI | Absci Corp | Casdin Capital, LLC | Dir | P - Purchase | $16.00 | +1.56M | 6.75M | +30% | +$25.00M |
| DI | 2021-07-28 | 2021-07-26 | ABSI | Absci Corp | Casdin Capital, LLC | Dir | C - Cnv Deriv | $0.00 | +973.3K | 973.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations